The tumor-suppressive miR-34a, which is transcriptionally regulated by megakaryocytic leukemia 1 (MKL1), directly targets FOXP3 mRNA, thereby limiting Treg differentiation and its tumor-promoting effects (99). The gene discussed is FOXP3; the disease is neoplasm.